AR006690A1 - Piperidinas y pirrolidinas, procedimiento para prepararlas, preparaciones farmaceuticas que las contienen y procedimiento para preparar estaspreparaciones farmaceuticas. - Google Patents
Piperidinas y pirrolidinas, procedimiento para prepararlas, preparaciones farmaceuticas que las contienen y procedimiento para preparar estaspreparaciones farmaceuticas.Info
- Publication number
- AR006690A1 AR006690A1 ARP970101562A ARP970101562A AR006690A1 AR 006690 A1 AR006690 A1 AR 006690A1 AR P970101562 A ARP970101562 A AR P970101562A AR P970101562 A ARP970101562 A AR P970101562A AR 006690 A1 AR006690 A1 AR 006690A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical preparations
- prepare
- procedure
- hal
- mono
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 150000003053 piperidines Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 1
- -1 3-indolyl Chemical group 0.000 abstract 1
- 101100294115 Caenorhabditis elegans nhr-4 gene Proteins 0.000 abstract 1
- 208000012661 Dyskinesia Diseases 0.000 abstract 1
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000020358 Learning disease Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 230000006399 behavior Effects 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 201000003723 learning disability Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 239000003727 serotonin 1A antagonist Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19615232A DE19615232A1 (de) | 1996-04-18 | 1996-04-18 | Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR006690A1 true AR006690A1 (es) | 1999-09-08 |
Family
ID=7791576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101562A AR006690A1 (es) | 1996-04-18 | 1997-04-18 | Piperidinas y pirrolidinas, procedimiento para prepararlas, preparaciones farmaceuticas que las contienen y procedimiento para preparar estaspreparaciones farmaceuticas. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0898569A1 (pt) |
| JP (1) | JP2000508670A (pt) |
| KR (1) | KR20000005505A (pt) |
| AR (1) | AR006690A1 (pt) |
| AU (1) | AU2696797A (pt) |
| BR (1) | BR9708677A (pt) |
| CA (1) | CA2252385A1 (pt) |
| CZ (1) | CZ330598A3 (pt) |
| DE (1) | DE19615232A1 (pt) |
| HU (1) | HUP9901389A3 (pt) |
| NO (1) | NO984861L (pt) |
| PL (1) | PL329351A1 (pt) |
| SK (1) | SK141998A3 (pt) |
| WO (1) | WO1997040038A1 (pt) |
| ZA (1) | ZA973301B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19756036A1 (de) | 1997-12-17 | 1999-06-24 | Merck Patent Gmbh | Amid- und Harnstoffderivate |
| US6150533A (en) * | 1998-04-08 | 2000-11-21 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
| DE69903930T2 (de) * | 1998-04-08 | 2003-07-17 | Wyeth, Madison | N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen |
| JP2002513018A (ja) * | 1998-04-29 | 2002-05-08 | アメリカン・ホーム・プロダクツ・コーポレイション | セロトニン作動薬 |
| AU4566399A (en) * | 1998-06-15 | 2000-01-05 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| US6376494B1 (en) | 1998-06-15 | 2002-04-23 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| US6239126B1 (en) | 1998-12-17 | 2001-05-29 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives |
| US6326381B1 (en) | 1998-12-17 | 2001-12-04 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetrahydropyidine amide derivates |
| NZ512282A (en) * | 1998-12-17 | 2002-09-27 | Wyeth Corp | Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5HT1A receptor activity |
| EP1140831A1 (en) * | 1998-12-17 | 2001-10-10 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity |
| CN1342074A (zh) * | 1999-01-28 | 2002-03-27 | 布里斯托尔-迈尔斯斯奎布公司 | 抗抑郁的杂环化合物 |
| EP1348019B9 (de) * | 2000-12-27 | 2012-04-18 | Axiogenesis Ag | System zur zell-und entwicklungsspezifischen selektion differenzierender embryonaler stammzellen; adulter stammzellen und embryonaler keinbahnzellen |
| KR100459917B1 (ko) * | 2001-12-14 | 2004-12-03 | (주)바이오뉴트리젠 | 페놀릭산 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물 |
| DE10337184A1 (de) | 2003-08-13 | 2005-03-10 | Gruenenthal Gmbh | Substituierte 3-Pyrrolidin-Indol-Derivate |
| UY36390A (es) | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
| CA2964276A1 (en) | 2014-11-05 | 2016-05-12 | Flexus Biosciences, Inc. | Immunoregulatory agents |
| JP2024523822A (ja) * | 2021-06-02 | 2024-07-02 | セント ジョセフズ ユニバーシティー | フッ素化トリプタミン化合物、その類似体、及びそれを使用する方法 |
| EP4469453A1 (en) | 2022-01-29 | 2024-12-04 | Suven Life Sciences Limited | Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3226392A (en) * | 1960-03-07 | 1965-12-28 | Sterling Drug Inc | 1-[n-aryl-n-acylaminoalkyl]-4-aryl-1,2,3,6-tetrahydropyridines, the corresponding piperidines and their salts |
| US3647790A (en) * | 1969-04-08 | 1972-03-07 | American Home Prod | Ouinoxalinyl-oxazolidines and -oxazines |
| US4782071A (en) * | 1986-11-03 | 1988-11-01 | Warner-Lambert Company | Tetrasubstituted urea cholinergic agents |
| AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
| FR2706894A1 (en) * | 1993-06-22 | 1994-12-30 | Synthelabo | N-Phenyl-N-(piperidinoalkyl)arylamide derivatives, their preparation and their application in therapeutics |
| GB9314758D0 (en) * | 1993-07-16 | 1993-08-25 | Wyeth John & Brother Ltd | Heterocyclic derivatives |
| EP0661266A1 (en) * | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Substituted cyclic amine compounds as 5HT2 antagonists |
| GB9411099D0 (en) * | 1994-06-03 | 1994-07-27 | Wyeth John & Brother Ltd | Piperazine derivatives |
-
1996
- 1996-04-18 DE DE19615232A patent/DE19615232A1/de not_active Withdrawn
-
1997
- 1997-04-14 BR BR9708677A patent/BR9708677A/pt not_active Application Discontinuation
- 1997-04-14 AU AU26967/97A patent/AU2696797A/en not_active Abandoned
- 1997-04-14 CZ CZ983305A patent/CZ330598A3/cs unknown
- 1997-04-14 SK SK1419-98A patent/SK141998A3/sk unknown
- 1997-04-14 WO PCT/EP1997/001853 patent/WO1997040038A1/en not_active Ceased
- 1997-04-14 PL PL97329351A patent/PL329351A1/xx unknown
- 1997-04-14 HU HU9901389A patent/HUP9901389A3/hu unknown
- 1997-04-14 KR KR1019980708295A patent/KR20000005505A/ko not_active Withdrawn
- 1997-04-14 CA CA002252385A patent/CA2252385A1/en not_active Abandoned
- 1997-04-14 JP JP9537685A patent/JP2000508670A/ja active Pending
- 1997-04-14 EP EP97920673A patent/EP0898569A1/en not_active Withdrawn
- 1997-04-17 ZA ZA9703301A patent/ZA973301B/xx unknown
- 1997-04-18 AR ARP970101562A patent/AR006690A1/es unknown
-
1998
- 1998-10-16 NO NO984861A patent/NO984861L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL329351A1 (en) | 1999-03-29 |
| HUP9901389A2 (hu) | 1999-08-30 |
| DE19615232A1 (de) | 1997-10-23 |
| SK141998A3 (en) | 1999-03-12 |
| NO984861D0 (no) | 1998-10-16 |
| NO984861L (no) | 1998-10-16 |
| CZ330598A3 (cs) | 1999-01-13 |
| EP0898569A1 (en) | 1999-03-03 |
| HUP9901389A3 (en) | 2000-09-28 |
| ZA973301B (en) | 1997-10-24 |
| AU2696797A (en) | 1997-11-12 |
| JP2000508670A (ja) | 2000-07-11 |
| WO1997040038A1 (en) | 1997-10-30 |
| KR20000005505A (ko) | 2000-01-25 |
| BR9708677A (pt) | 1999-08-03 |
| CA2252385A1 (en) | 1997-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR006690A1 (es) | Piperidinas y pirrolidinas, procedimiento para prepararlas, preparaciones farmaceuticas que las contienen y procedimiento para preparar estaspreparaciones farmaceuticas. | |
| LU90410I2 (fr) | Milnacipran (chlorhydrate) | |
| ATE206611T1 (de) | Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung | |
| AR004291A1 (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos. | |
| DK0889877T3 (da) | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer | |
| FI943948A0 (fi) | Heterosykliset hiilihappojohdannaiset | |
| DK0871606T3 (da) | Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet | |
| AR009770A1 (es) | Derivados de piperazina, un procedimiento para prepararlos, el empleo de estos compuestos para preparar un medicamento, las preparaciones farmaceuticasque los contienen y un procedimiento para obtener estas preparaciones farmaceuticas | |
| ES2195034T3 (es) | Inhibidor de metaloproteinasas, composicion farmaceutica que contiene este inhibidor y su utilizacion farmaceutica, y procedimientos que sirven para su preparacion. | |
| DK0544819T3 (da) | Indolderivater, som inhiberer leukotrienbiosyntese | |
| HUP0400365A2 (hu) | 3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények | |
| ES2075202T3 (es) | Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen. | |
| DK0696281T3 (da) | Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater | |
| NO922380L (no) | Substituerte 4-fenyl-4-piperidinkarboksamider med baade lokal anestetisk og analgetisk effekt samt fremgangsmaater for deres fremstilling | |
| BR9805152A (pt) | Parceiros de ligação para inibidores de quinases dependentes de ciclina e seu uso para busca de inibidores e para a diagnose ou terapia de uma doença. | |
| NO973857D0 (no) | 1-aryl-2-acylamino-etanforbindelser og deres anvnedelse som neurokinin-, spesielt neurokinin-1-antagonister | |
| ES2043863T3 (es) | Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina. | |
| ES2179523T3 (es) | Metodo para aumentar la biodisponibilidad de la fexofenadina y sus derivados. | |
| ES2029879T3 (es) | Procedimiento para producir derivados de aminas sustituidas. | |
| NO985676D0 (no) | Forbindelser med colchicinstruktur, deres anvendelse som legemidler og blandinger som inneholder dem | |
| AR005549A1 (es) | Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos. | |
| ES2182090T3 (es) | Nuevos derivados de pirrol. | |
| ES2125474T3 (es) | Derivados de piridazinona o sus sales, procedimentos para su produccion y agentes anti-shock que los contienen. | |
| ES2061478T3 (es) | Derivados de teofilin-metil-ditiolano y teofilin-metil-ditianilo, un metodo para su preparacion, y composiciones farmaceuticas que los contienen. | |
| AR002273A1 (es) | Derivados de la 4-amino-benzoilguanidina, un procedimiento para prepararlos, el empleo de los mismos para preparar un medicamento, laspreparaciones farmaceuticas que las contienen y un procedimiento para preparar estas preparaciones farmaceuticas. |